MedTrace Logo

The Effect of Content of Barley Beta-glucans in Bread on Postprandial Blood Sugar

NCT03878576 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2019-03-19

No results posted yet for this study

Summary

The effect of content of barley beta-glucans in bread on postprandial blood sugar will be measured with open-label crossover study. Study will be conducted in Slovenia on 10-12 adult subjects who will test three barley beta-glucan containing bread formulations (food) in comparison with a reference white bread. Objective of the study is to investigate the influence of the content of barley beta-glucan in bread on glycaemic index (incremental area under the curve (IAUC) for the blood glucose response curve for barley beta-glucan containing breads in comparison to reference white bread.

Conditions

  • Glycemic Index

Interventions

OTHER

REFERENCE: white bread - BGL0 [RP]

Determination of glycemic response after consumption of BGL0.

OTHER

TEST: b-glucan enriched bread - BGL2 [IP1]

Determination of glycemic response after consumption of BGL0.

OTHER

TEST: b-glucan enriched bread - BGL3 [IP2]

Determination of glycemic response after consumption of BGL0.

OTHER

TEST: b-glucan enriched bread - BGL4 [IP3]

Determination of glycemic response after consumption of BGL0.

Sponsors & Collaborators

  • Community Health Centre Ljubljana

    collaborator OTHER

  • Slovenian Research Agency

    collaborator OTHER

  • Valens Int. d.o.o., Slovenija

    collaborator INDUSTRY

  • Institute of Nutrition, Slovenia (Nutris)

    lead OTHER

Principal Investigators

  • Igor Pravst, PhD · Institut za nutricionistiko

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-26
Primary Completion
2018-12-07
Completion
2018-12-07

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03878576 on ClinicalTrials.gov